Progress in The Tumor Suppressor, ARF
DOI:
Author:
Affiliation:

Clc Number:

Fund Project:

This work was supported by a grant from The National Basic Research Programs of China (G1999053901).

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    The INK4a/ARF gene locus on human chromosome 9p21, is one of the most frequent targets of inactivating mutations in the human tumors. Containing two different promoters, INK4a/ARF can encode two distinct proteins in alternative reading frames, p16INK4a and p14ARF (the mouse homologues is called p19ARF). p16 is a recognized tumor suppressor that induces a G1 cell cycle arrest by inhibiting the phosphorylation of pRb by CDK4/6. While ARF inhibits oncoprotein MDM2, resulting in the stabilization of p53. These activities of ARF promote p53-mediated G1 and G2/M cell cycle arrests or apoptosis. So just like p16, the ARF protein also acts as a tumor suppressor.

    Reference
    Related
    Cited by
Get Citation

PENG Li-Xia, ZHANG Wei, HE Da-Cheng, LIU Hui-Tu. Progress in The Tumor Suppressor, ARF[J]. Progress in Biochemistry and Biophysics,2002,29(6):842-846

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:April 16,2002
  • Revised:June 05,2002
  • Accepted:
  • Online:
  • Published: